missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. MA551754

Invitrogen™ Clenoliximab Chimeric Recombinant Mouse Monoclonal Antibody (CE9.1 (Clenoliximab))
GREENER_CHOICE

Catalog No. MA551754
Change view
Click to view available options
Quantity:
200 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
MA551754 200 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. MA551754 Supplier Invitrogen™ Supplier No. MA551754
Only null left

Description

Mouse Recombinant Monoclonal Antibody

The antibody binds to human CD4 with a Kd of 1.0 nM and an ED50 of 0.2 μg/mL.

Clenoliximab is a chimeric monoclonal antibody fromMacaca irusagainst CD4 which acts as an immunomodulator. It has investigated for the treatment of rheumatoid arthritis.

Specifications

Antigen Clenoliximab Chimeric
Applications ELISA, Flow Cytometry, Inhibition Assays, Immunohistochemistry, Surface Plasmon Resonance
Classification Recombinant Monoclonal
Clone CE9.1 (Clenoliximab)
Concentration 1 mg/mL
Conjugate Unconjugated
Formulation PBS with 0.02% ProClin 300
Gene Alias 4PE; IDEC-151
Host Species Mouse
Immunogen Domain 1 of human CD4.
Purification Method Protein A
Quantity 200 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human, Chimpanzee
Content And Storage Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Product Type Antibody
Form Liquid
Isotype IgG1 λ
Show More Show Less